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Trends in Emergency Department Utilization
Among Women With Leiomyomas in the
United States
Chelsea N. Fortin, MD, Charley Jiang, MS, Martina T. Caldwell,
Vanessa Dalton, MD, and Erica E. Marsh, MD, MSCI
OBJECTIVE: To describe trends in emergency department
(ED) visits in the United States with a primary diagnosis of
leiomyomas, subsequent admissions, and associated charges.
METHODS: The Healthcare Cost and Utilization Project
Nationwide Emergency Department Sample database was
used to retrospectively identify all ED visits from 2006 to
2017 among women aged 18–55 years with a primary diagnosis of leiomyomas as indicated by International Classification of Diseases (ICD) diagnosis codes. Trends in ED visits
and subsequent admissions were analyzed and stratified by
patient and hospital characteristics. Secondary ICD codes,
Current Procedural Terminology codes, and hospital
charges were analyzed. A multivariate regression model
was used to identify predictors of admission.
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RESULTS: Although the number of ED visits for leiomyomas
increased from 28,732 in 2006 to 65,685 in 2017, the
admission rate decreased, from 23.9% in 2006 to 11.1% in
2017. Emergency department visits for leiomyomas were
highest among women who were aged 36–45 years (44.5%),
in the lowest income quartile (36.1%), privately insured
(38.3%), and living in the South (46.2%). Admission was more
likely at nonteaching hospitals (odds ratio [OR] 1.23, 95% CI
1.08–1.39) or those located in the Northeast (OR 1.39, 95% CI
1.15–1.68). Patient characteristics associated with admission
included older age (26–35 years: OR 1.42, 95% CI 1.21–1.66;
36–45 years: OR 2.01, 95% CI 1.72–2.34; 46–55 years: OR 2.60,
95% CI 2.23–3.03) and bleeding-related complaints (OR
14.92, 95% CI 14.00–15.90). Admission was least likely in uninsured patients (Medicare: OR 1.37, 95% CI 1.21–1.54; Medicaid: OR 1.26, 95% CI 1.16–1.36; private: OR 1.44, 95% CI
1.32–1.56).
CONCLUSION: Although ED visits for leiomyomas are
increasing, admission rates for these visits are decreasing.
The substantial decline in admissions suggests many of
these visits could potentially be addressed in a non–acutecare setting. However, when women with leiomyomas
present with a bleeding-related complaint, the odds of
admission increase 15-fold. There is an apparent disparity
in likelihood of admission based on insurance type.
(Obstet Gynecol 2021;137:897–905)
DOI: 10.1097/AOG.0000000000004333

U

terine leiomyomas are the most common benign
gynecologic condition in the United States, with
a prevalence of up to 70% by age 50 years.1 Although
the majority of leiomyomas are asymptomatic, approximately 25–50% of patients will experience symptoms,
most commonly heavy menstrual bleeding and pelvic
pain or pressure.2 Because of their associated morbidity,
leiomyomas continue to be the leading cause of hysterectomy in the United States3 and a cause of protracted
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symptoms for which there are limited long-term treatment
options.
Although leiomyomas are often a chronic condition, many women with symptomatic leiomyomas will
seek evaluation in the emergency department (ED). It
has been estimated that one in five will visit the ED in
the first year after their diagnosis of leiomyomas.4
Furthermore, women with leiomyomas have more
ED visits than women without leiomyomas.4 Receiving care in the ED is costly, and has been found to be
10 times more expensive than receiving care at an
urgent care center for the same diagnosis.5 The total
annual costs of leiomyomas have been estimated to be
as high as $5.9–34.4 billion U.S. dollars.6 Both ED
visits and hospital admissions contribute substantially
to the overall economic burden that leiomyoma disorders pose to individual patients and society.
Gaining insight into the volume of these visits and
drivers of admission could help redirect appropriate
patients to alternative care settings, resulting in
significant cost savings. However, little is known
currently about leiomyoma-related care in the ED or
about the women who seek care in this setting. The
objective of this study was to describe national trends
in leiomyoma-related ED visits and associated hospital charges, as well as to determine factors associated
with subsequent hospital admission.

METHODS
Information on ED visits for leiomyomas in the United
States from 2006 to 2017 was obtained from the
Nationwide Emergency Department Sample, which is
a part of the Healthcare Cost and Utilization Project,
and sponsored by the Agency for Healthcare Research
and Quality. The Nationwide Emergency Department
Sample is the largest all-payer publicly available database of ED visits in the United States.7 This database
contains information from 33.5 million ED visits at 984
hospitals to create a 20% stratified sample of U.S.
hospital-based EDs. Weighted, the database describes
more than 100 million ED visits annually. Hospital
and patient characteristics, as well as information on
the nature of the visits, are included in the database.
The University of Michigan Institutional Review Board
reviewed this study and determined that it was exempt
because the data are deidentified and publicly available.
Emergency department visits were selected for
inclusion if they involved female patients aged 18–55
years old with a diagnosis of leiomyomas. International Classification of Diseases (both ninth [ICD-9]8
and tenth [ICD-10]9 revisions) diagnosis codes were
used to identify visits in which the primary diagnosis
was leiomyomas (ICD-9 codes: 218.X, 218.0, 218.1,
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218.2, and 218.9; ICD-10 codes: D25.X, D25.0,
D25.1, D25.2, and D25.9).
The weighted percentage of ED visits among this
cohort was calculated for each year during 2006–
2017, as well as, overall, during the study period.
Emergency department visits for leiomyomas were
stratified by a number of covariates, including age,
income, payment type, and hospital location and type.
Age was grouped into four categories: 18–25; 26–35;
36–45; and 46–55 years. Income quartile by ZIP code
was included in the Nationwide Emergency Department Sample database. No patient-specific income
data were provided. Payment type included five categories: Medicaid, Medicare, private insurance, uninsured, and other. The uninsured category included
insurance type “self-pay” and “no charge.”10 “No
charge” indicated that the hospital did not charge
any fee for the encounter and included, for example,
charity, nonpayment, and professional courtesy. The
geographic location of the hospital was categorized as
Midwest, Northeast, South, or West. Hospital type
was divided into teaching and nonteaching. Teaching
hospitals were all metropolitan based. Nonteaching
hospitals included both metropolitan nonteaching
and nonmetropolitan hospitals. Nonmetropolitan
teaching hospitals were not classified separately by
the Nationwide Emergency Department Sample, as
these hospitals were rare.
Secondary diagnoses associated with leiomyomarelated ED visits were also identified using ICD-9 and
ICD-10 codes (Appendix 1, available online at http://
links.lww.com/AOG/C247). Diagnosis codes that
represented similar clinical entities were grouped
together. For instance, code N939 (abnormal uterine
and vaginal bleeding, unspecified) and code N938
(other specified abnormal uterine and vaginal bleeding), were grouped together as “bleeding-related”
diagnoses. Current Procedural Terminology (CPT)
codes associated with leiomyoma-related ED visits
were also identified to ascertain tests and procedures
ordered during these visits (Appendix 2, available online at http://links.lww.com/AOG/C247). Again,
clinically similar CPT codes were grouped together,
such as CPT code 76856 (nonobstetric pelvic ultrasonography, real time with image documentation; complete) and CPT code 76830 (nonobstetric transvaginal
ultrasonography) both being categorized as “pelvic
ultrasound.” The frequencies of each group of secondary diagnoses and each group of CPT codes were
calculated.
Emergency department charges were obtained
from the Nationwide Emergency Department Sample
database and adjusted for inflation using the
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Consumer Price Index11 related to the 2017 U.S. dollar. If ED charges were excessively low or high, the
value was set to missing by the Nationwide Emergency Department Sample. Missing charge values
were treated as missing at random and imputed for
the calculation of total charges. Age, region, income,
and the presence of a leiomyoma diagnosis were
included as covariates for the imputation analysis.
Average annual percentage changes of charges were
estimated by fitting trend data to a log-linear model
using Joinpoint 4.7.0.0.
SAS 9.4 was used to perform the statistical
analyses. Descriptive statistics were calculated as
counts and percentages for categorical variables and
means for continuous variables. t test, x2 test, and Ftest were used to carry out significant difference tests,
and P,0.05 was considered statistically significant.
A weighted multivariable logistic regression
model was constructed to determine factors associated
with hospital admission for leiomyoma-related visits.
The patient and hospital characteristics were used as
covariates in the model. The dependent variable was
an indicator of ED visit admission status. The
independent variables included in the logistic model
were age group, region, payment type, income
quartile by ZIP code, hospital teaching status, concomitant diagnosis of bleeding, and concomitant
diagnosis of pain. The logistic model estimation
incorporated different weights based on national
hospital stratum. We obtained maximum likelihood
estimates of regression parameters and standard
errors, as well as the corresponding odds ratios and
CIs for each independent predictor.

RESULTS
During the study period, there were a total of 533,963
ED visits for leiomyomas among women aged 18–55
years. There were 487,688,338 total ED visits by
women in this age group for all diagnoses during
the study period. The number of ED visits for leiomyomas within this population increased 129% from
2006 (28,732 visits) to 2017 (65,685 visits) (Fig. 1).
The proportion of all ED visits that were for a primary
diagnosis of leiomyomas also increased over the study
period, from 0.079% in 2006 to 0.154% in 2017
(Table 1), suggesting that the increase was not simply
from an increase in overall population volume. The
overall admission rate for women aged 18–55 years
presenting to the ED for leiomyomas during the 12year study period was 16.3% and decreased by more
than half, from 23.9% in 2006 to 11.1% in 2017. In
comparison, the rate of admission for all other nonleiomyoma diagnoses presenting to the ED was rela-
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tively stable throughout the study period (9.2% in
2006 and 8.1% in 2017). The overall admission rate
for patients presenting to the ED with all other diagnoses during the study period was only 8.5%.
Table 2 depicts the descriptive characteristics of
ED visits and admissions for leiomyomas during the
entire study period. Almost half (44.5%) of the women
were aged 36–45 years; only 3.4% were aged 18–25
years. Women presenting to the ED were most likely
to be in the lowest income quartile (36.1%) and least
likely to be in the highest income quartile (16.4%).
The majority of ED visits for leiomyomas during the
study period were paid by private insurance (38.3%),
Medicaid (27.1%), or self-pay (24.4%). Regarding geographic location, women presenting to the ED with
leiomyomas during the study period were most likely
to be from the South (46.2%) and least likely to be
from the Midwest (12.2%).
The most common secondary diagnoses among
patients with a primary diagnosis of leiomyomas were
those related to blood loss—anemia or abnormal menstrual bleeding (40.9%). The next most common secondary diagnoses were those related to abdominal or
pelvic pain (21.4%). Table 3 shows the most common
procedures and tests ordered during ED visits for leiomyomas. The most commonly ordered tests were
chemistry studies (61.9%), hematologic studies
(58.0%), and pelvic or abdominal ultrasonograms
(57.3%). We found that 14.2% of patients with a primary diagnosis of leiomyomas received intravenous
hydration. This was significantly higher than the 8.6%
of age-matched women presenting to the ED with all
other diagnoses during the study period (P,.001).
Furthermore, 1.8% of women with a primary diagnosis of leiomyomas received a blood transfusion. This
was also significantly higher than the 0.1% of agematched women with all other diagnoses who
received a blood transfusion (P,.001).
From 2006 to 2017, the median ED visit charges
for leiomyomas more than doubled, from $2,586 to
$6,193. Average ED charges for leiomyomas were
consistently higher than charges for non–leiomyomarelated visits (P,.001) (Fig. 2). Furthermore, the total
ED visit charges for leiomyomas increased by 445%
during the study period, totaling nearly $500 million
in 2017. The annual average percentage change for
leiomyoma-related ED visit charges was significantly
higher than that of all other age-matched diagnoses
during the overall study period (8.7% vs 7.3%;
P,.01).
Table 2 also shows the multivariate analysis of
predictors of hospital admission. The probability of
hospital admission for leiomyomas increased with
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Fig. 1. Yearly emergency department (ED) visits for leiomyomas
among women aged 18–55 years by
admitted status, 2006–2017.
Fortin. Emergency Department Visits For
Leiomyomas. Obstet Gynecol 2021.

age, with women aged 18–25 years being significantly
less likely to be admitted than older women (26–35
years: odds ratio [OR] 1.42, 95% CI 1.21–1.66; 36–45
years: OR 2.01, 95% CI 1.72–2.34; 46–55 years: OR
2.60, 95% CI 2.23–3.03). Emergency department visits in the Northeast were significantly more likely to
result in admission than those in other regions (OR
1.39, 95% CI 1.15–1.68). Admission was least likely to
occur in the South. Admission was least likely in uninsured patients (Medicare: OR 1.37, 95% CI 1.21–
1.54; Medicaid: OR 1.26, 95% CI 1.16–1.36; private:
OR 1.44, 95% CI 1.32–1.56). Unadjusted x2 analyses
demonstrated that women in the lowest income quartile were less likely to be admitted. Income quartile by
ZIP code did not correlate significantly with admission in our logistic regression model. Patients seen at
nonteaching hospitals were more likely to be admitted
than those seen at teaching hospitals (OR 1.23, 95%
CI 1.08–1.39). Finally, women with leiomyomas who

presented to the ED with bleeding were significantly
more likely to be admitted (OR 14.92, 95% CI 14.00–
15.90). Patients who presented with pain were significantly less likely to be admitted (OR 0.29, 95% CI
0.27–0.33).

DISCUSSION
In this analysis of a large nationally representative
database, ED visits with a primary diagnosis of
leiomyomas progressively increased while admission
rates decreased over the 12-year study period.
Approximately one in 10 ED visits for leiomyomas
resulted in admission in 2017. The growing disparity
between the number of ED visits for leiomyomas and
the number of those visits resulting in admission
warrants exploration. It is possible that women are
increasingly using the ED for nonurgent leiomyomarelated issues. Alternatively, this finding could potentially reflect changes in ED care patterns, such as

Table 1. Proportion of Total Emergency Department Visits for Leiomyomas Among Women Aged 18–55
Years, 2006–2017
Year

Total ED Visits (All Diagnoses)

ED Visits for Leiomyomas

Proportion of Total ED Visits for Leiomyomas (%)

2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017

36,241,653
37,165,635
38,522,166
39,542,196
40,788,108
40,477,498
41,607,380
41,574,457
42,761,683
42,755,919
43,477,273
42,774,371

28,732
31,933
33,850
37,728
40,304
42,918
44,985
45,461
53,033
51,843
57,491
65,685

0.079
0.086
0.088
0.095
0.099
0.106
0.108
0.109
0.124
0.121
0.132
0.154

ED, emergency department.
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Table 2. Characteristics of Emergency Department Visits and Admissions for Leiomyomas Among Women
Aged 18–55 Years, 2006–2017, and Associated Logistic Regression*
Admission
Variable
Total
Age (y)
18–25‡
26–35
36–45
46–55
Region
Northeast
Midwest
South‡
West
Insurance
Medicare
Medicaid
Private
Uninsured‡
Other
Income quartile
Lowest
2nd
3rd‡
Highest
Teaching status
Teaching‡
Nonteaching§
Metropolitan status
(population)
Metro (more than 1
million)
Metro (50,000 to less
than 1
million)
Nonmetro‡
Concomitant diagnoses
Pain-related
No‡
Yes
Bleeding-related
No‡
Yes

Total ED Visits†

Admitted†

Not
Admitted†

533,963 (100)

87,025 (16.3)

446,938 (83.7)

18,182
108,986
237,801
168,994

(3.4)
(20.4)
(44.5)
(31.6)

1,252
11,214
38,604
35,956

(1.4)
(12.9)
(44.4)
(41.3)

16,930
97,772
199,197
133,038

(3.8) .001
(21.9)
(44.6)
(29.8)

1.0
1.551 (1.35–1.79)
2.62 (2.28–3.01)
3.654 (3.18–4.2)

120,721
65,290
246,436
101,517

(22.6)
(12.2)
(46.2)
(19)

21,516
10,487
35,254
19,768

(24.7)
(12.1)
(40.5)
(22.7)

99,205
54,802
211,182
81,749

(22.2) .001
(12.3)
(47.3)
(18.3)

1.299 (1.12–1.51)
1.146 (0.95–1.39)
1.0
1.449 (1.3–1.62)

1.389 (1.15–1.68)
1.126 (0.96–1.32)

21,089
144,884
204,299
143,111
19,603

(3.9)
(27.1)
(38.3)
(26.8)
(3.7)

3,575
24,589
35,886
19,134
3,741

(4.1)
(28.3)
(41.2)
(22.0)
(4.3)

17,514
120,295
168,414
123,978
15,863

(3.9) .001
(26.9)
(37.7)
(27.8)
(3.5)

1.323 (1.18–1.48)
1.324 (1.2–1.46)
1.38 (1.27–1.5)
1.0
1.528 (1.29–1.81)

1.366 (1.21–1.54)
1.258 (1.16–1.36)
1.435 (1.32–1.56)

192,734
129,503
112,878
87,679

(36.1)
(24.3)
(21.1)
(16.4)

29,415
20,461
18,303
15,231

(33.8)
(23.5)
(21)
(17.5)

163,319
109,041
94,574
72,448

(36.5) .001
(24.4)
(21.2)
(16.2)

0.931 (0.87–1)
0.97 (0.91–1.04)
1.0
1.086 (1.01–1.17)

P

OR (95% CI)

Adjusted OR
(95% CI)

1.418 (1.21–1.66)
2.005 (1.72–2.34)
2.602 (2.23–3.03)

1.114 (0.99–1.26)

1.535 (1.31–1.79)
1.019 (0.94–1.1)
1.019 (0.95–1.1)
1.01 (0.93–1.09)

313,247 (58.7)
220,716 (41.3)

50,221 (57.7)
36,804 (42.3)

263,025 (58.9) .001
183,913 (41.1)

1.0
1.048 (0.94–1.17)

1.225 (1.08–1.39)

375,185 (70.3)

63,565 (73)

311,620 (69.7) .003

1.316 (1.18–1.47)

1.287 (1.13–1.47)

120,149 (22.5)

18,081 (20.8)

102,068 (22.8)

1.143 (0.97–1.35)

1.19 (0.98–1.44)

36,403 (6.8)

4,886 (5.6)

31,517 (7.1)

377,952 (70.8)
156,011 (29.2)

18,346 (21.1)
68,679 (78.9)

359,606 (80.5) .001
87,332 (19.5)

1.0
0.22 (0.2–0.25)

427,162 (80)
106,801 (20)

81,749 (93.9)
5,276 (6.1)

345,413 (77.3) .001
101,525 (22.7)

1.0
15.415 (14.48–
16.41)

1.0

0.294 (0.27–0.33)

14.919 (14–15.9)

ED, emergency department; OR, odds ratio.
Data are n (%) unless otherwise specified.
* Variables in the final logistic regression model included age group, region, insurance, teaching status, metropolitan status, and
concomitant diagnoses.
†
Count (n) estimates are unweighted; percentage estimates are weighted using Healthcare Cost and Utilization Project discharge weights,
which are representative of the reported total of ED visits in the United States. The percentages within each covariate are column
percentages. Some counts do not sum to totals because of missing data for factor; percentages calculated from all nonmissing data.
Fewer than 0.5% of the data were missing.
‡
Reference group.
§
Nonteaching hospitals included both metropolitan nonteaching and nonmetropolitan hospitals.
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Table 3. Most Common Current Procedural
Terminology Codes Associated With
Emergency Department Visits for
Leiomyomas Among Women Aged 18–55
Years, 2006–2017
Procedure or Test

Frequency (%)

Chemistry studies
Hematologic studies
Pelvic or abdominal ultrasonography
Urinalysis or urine culture
STI or vaginitis screen
Injections and infusions*
Pregnancy test
CT of abdomen or pelvis
Blood typing

61.9
58.0
57.3
47.9
39.6
38.5
36.1
18.9
16.7

STI, sexually transmitted infection; CT, computed tomography.
* Defined as “Therapeutic, Prophylactic, & Diagnostic Injections &
Infusions,” per the Centers for Medicare & Medicaid Services.34

managing pain control and administering blood
transfusions in the ED as opposed to admitting.
Increasing use of effective medical therapies in the
ED, such as tranexamic acid, to manage heavy
bleeding, could also contribute to the decreasing
admission rate. Because admission rates varied significantly by region and payer, this pattern may also
result from local policy or health care professional
biases. The increasing number of leiomyoma-related
ED visits is particularly interesting given the recent
finding of a decreasing trend of new leiomyoma
diagnoses among women aged 18–65 years between
2005 and 2015.12 Future research exploring patients’

motivations for seeking care in the ED may provide
clarification.
The overall economic burden of symptomatic
leiomyomas on society has been estimated to be $5.9–
34.4 billion U.S. dollars annually in both direct costs
and indirect costs.6 We found an average ED charge
of more than $6,000 per visit and $500 million in total
charges in 2017. Furthermore, average ED charges for
leiomyoma-related visits were consistently twice as
high as ED charges for other diagnoses. The high proportion of patients who received costly ED-based
imaging studies likely contributed significantly to
these costs. It is likely that many of these patients were
appropriate candidates for outpatient imaging, which
potentially could have saved significant money and
resources. Prior studies have similarly found that
women with leiomyomas incur total health care costs
of more than twice that of their counterparts without
leiomyomas.13 This cohort of women should be targeted for intervention to improve access to outpatient
care, thereby mitigating unnecessary, costly ED
utilization.
Based on the results of our logistic regression, we
further characterized patients who are more likely to
be admitted after presenting to the ED for leiomyomas. Women who presented with a bleeding-related
complaint were 15-times more likely to be admitted
than those who did not present with a bleedingrelated complaint. On the contrary, if the primary
complaint was pain-related, the odds of admission
were significantly lower. These associations are
logical, because bleeding-related issues can quickly

Fig. 2. National estimates of average emergency department charges
in 2017 U.S. dollars for women
aged 18–55 years, 2006–2017.
IQR, interquartile range.
Fortin. Emergency Department Visits For
Leiomyomas. Obstet Gynecol 2021.
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lead to hemodynamic instability, a scenario that
almost exclusively warrants admission. Pain-related
leiomyoma symptoms are poorly understood, are
often multifactorial, and may not be directly related
to leiomyomas when present. Pain is also less likely
to be emergent in nature and can often be managed
as an outpatient.
The probability of admission was significantly
lower among women aged 18–25 years, and nearly
nine out of every 10 women admitted for leiomyomas
were aged 36–55 years old. This finding is consistent
with results from prior studies. Cox et al14 analyzed
reproductive health-related ED visits by women in
Maryland from 1999 to 2005 and reported an
increased odds of admission with increasing age. Several other studies have looked specifically at women
with leiomyomas, and have all concluded that the
hospitalization rate for leiomyomas increases with
age, peaking among women aged 40–54 years.15–17
Admission rates are lowest among younger women,
possibly because of different perceptions of what constitutes a medical emergency leading to higher careseeking behavior. Indeed, prior research has demonstrated that young adults receive a greater proportion
of their care in the ED compared with older adults.18
Furthermore, younger adults are least likely to report
the seriousness of their medical problem as the reason
for seeking care in the ED compared with older age
groups.19 Additionally, older women may have more
comorbidities contributing to their leiomyoma-related
ED visits, increasing their rates of admission. Finally,
it is also likely that younger women have less leiomyoma burden.
Women in the South had the lowest probability of
hospital admission, though the number of leiomyomarelated ED visits in this region was highest. Although
the high volume of ED visits in the South may be in
part because it is the most populous region in the
country as defined by the Nationwide Emergency
Department Sample,20 it is also known to be the
region with the highest prevalence of leiomyomas.21
Regional differences in leiomyoma prevalence could
largely be explained by differences in racial makeup.
Black women, who are disproportionately affected by
leiomyomas, comprise a greater proportion of the
total population in the South.22 Prior Nationwide
Emergency Department Sample studies have also
demonstrated significant variation in hospital admission rates across U.S. regions for other medical conditions.23–26 Potential factors contributing to this
variation include regional differences in health care
access, systemic racism, disease severity, physician
density, and environmental factors.
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Income was not found to be a significant predictor of hospital admission. There were, however,
notable differences in ED use across income quartiles.
Emergency department visits for leiomyomas were
highest among women in the lowest income bracket.
Overall health care utilization has previously been
shown to be influenced by socioeconomic status.27 In
a large national cross-sectional study, Nicholson
et al28 found a significant inverse relationship between
ED usage for gynecologic conditions and median
household income. There are likely numerous reasons
to explain this finding. For instance, many lowincome women do not have a primary care physician
and report limited access to primary care services.29
Additionally, studies have found that patients of lower
socioeconomic status prefer to receive medical care in
the ED over ambulatory care centers owing to affordability and trust in the technical quality of care.30 As a
result, many of these women use the ED for their
regular source of medical care.29
Given the observed association between number
of ED visits and lower socioeconomic status, we had
anticipated that the most frequently billed payer
would be Medicaid. Indeed, Nicholson et al28 found
that ED visits for gynecologic conditions were three
times more common among women with Medicaid
compared with private insurance. The results of our
analysis unexpectedly showed that the most frequently billed payer for leiomyoma-related ED visits
was private insurance. Potential explanations could
include higher primary care physician referrals to
the ED among the privately insured or the expansion
of private coverage under the Affordable Care Act.
Akosa Antwi et al looked at the effect of the Affordable Care Act on patterns of ED use among adults
aged 19–29 years. From 2007 to 2011, the fraction
of privately insured patients increased and the fraction
of those insured through Medicaid decreased.31 Our
results also showed that women who were uninsured
were least likely to be admitted for their leiomyomas.
Prior studies have demonstrated that admission rates
for several other conditions are higher in privately
insured women and lower in the uninsured.32,33
Because the Nationwide Emergency Department
Sample database does not provide detailed clinical
data or associated outcomes data, we were unable to
elucidate whether this apparent disparity is being
driven by unnecessary admissions of the privately
insured or inappropriate discharges of the uninsured.
The former would suggest current practices are
contributing to unnecessary health care expenditures,
and the latter means that a vulnerable cohort of
patients is being placed at risk for suboptimal care.
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Other possible explanations to explain this disparity
include differences in disease severity or patient
choice regarding admission. Reasons for the observed
variation in admission rates based on insurance
coverage warrants further investigation.
Our study has some limitations. First, patients
with several ED visits during the study period were
potentially represented more than once, because
analyses were visit-based not patient-based. Second,
there are limitations associated with the use of ICD
codes, which are intended for billing purposes, not
disease surveillance, and do not perfectly capture the
clinical picture of the visit. It is also possible that the
transition from ICD-9 to ICD-10 that occurred during
the study period resulted in coding errors and
disruptions in observed rates. We did not, however,
notice any sharp or unexplained trend changes during
this period. Finally, the Nationwide Emergency
Department Sample database does not contain information on race or ethnicity or patient-specific income
levels or other socioeconomic variables, which limited
our ability to assess the effect of social determinants of
health.
Despite these limitations, this work has many
strengths. It is based on the largest, publicly available
all-payer ED database in the United States, with
information on 33.5 million ED visits derived from
984 hospitals. The large number of ED records in the
Nationwide Emergency Department Sample database
decreases the risk of sampling error. Furthermore,
estimates from the Nationwide Emergency Department Sample database are nationally representative,
increasing the external validity of our findings.
Finally, our data were stratified by several key
variables, providing a comprehensive understanding
of ED visits for leiomyomas in the United States.
This nationally representative analysis provides a
foundation for understanding ED visits and hospitalizations where uterine leiomyomas are the primary
diagnosis. These encounters impart a significant and
increasing economic burden on patients, our health
care system, and society, and highlight an opportunity
to change the trajectory of ED utilization for this often
chronic and typically nonemergent condition.
Improving our understanding of patients with leiomyomas who present to the ED, but are not admitted,
will help target interventions to better care for these
patients in the outpatient setting and ultimately reduce
the burden of leiomyomas for both patients and
society. Finally, there is an apparent disparity in the
likelihood of admission based on insurance type. This
finding warrants further study to ensure that all
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women presenting with leiomyomas receive equitable
care.
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